You are viewing an old version of this page. View the current version.
Compare with Current View Page History
« Previous Version 10 Current »
FDA Erlotinib (Tarceva) (attachment)
Overall survival analyses of first-line erlotinib
EGFR Exon 19 Deletion in Non-Small Cell Lung Cancer
File Modified No files shared here yet.